Nicholas J Dankanich

Nicholas J. Dankanich serves as a Contract Specialist at the Naval Medical Logistics Command (N62645), where he plays a pivotal role in securing critical medical logistics capabilities for U.S. Navy and Marine Corps forces worldwide. He manages the full lifecycle of procurements for advanced diagnostic equipment, in-vitro diagnostic substances, analytical laboratory instruments, and specialized surgical tools essential to combat casualty care and point-of-care clinical readiness. His acquisitions directly support the Command’s mission to sustain a resilient, globally responsive medical supply chain, ensuring warfighters have access to cutting-edge medical technologies under austere operational conditions. Dankanich collaborates with a diverse array of contractors, including manufacturers of medical devices, diagnostic reagent producers, and technical consulting firms providing lifecycle support and validation services for clinical instrumentation. His contracting approach emphasizes performance-based requirements and technical compliance, fostering long-term partnerships with vendors capable of meeting stringent DoD quality and traceability standards. While no single contractor dominates his portfolio, he consistently engages with firms possessing robust FDA-regulated manufacturing capabilities and defense-grade supply chain security protocols. His procurement activity is entirely non-set-aside, reflecting a mission-driven focus on technical capability and rapid deployment over socioeconomic preferences. This reflects the urgent, high-stakes nature of medical logistics in expeditionary environments, where availability, reliability, and regulatory compliance take precedence over small business set-asides. Dankanich’s primary procurement focus centers on NAICS 325413 (in-vitro diagnostic manufacturing), 334516 (analytical laboratory instrumentation), and 339112 (surgical and medical instrument manufacturing), with additional support for technical consulting under 541690. His expertise lies in acquiring complex, regulated medical technologies requiring validation under ISO 13485 and FDA 21 CFR Part 820, demonstrating deep familiarity with the intersection of clinical diagnostics, military medical doctrine, and defense acquisition regulation.